{"id":"W4294942902","doi":"10.1016/j.jtho.2022.07.786","title":"EP08.02-103 Lorlatinib for ALK+ NSCLC Patients Pretreated with Second-Generation ALK Inhibitors: Canadian Real-World Experience","year":2022,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Medicine; Internal medicine; Cancer research; Oncology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006266282,0.0003955725,0.0003500908,0.000205923,0.001112981,0.0012787,0.0004478876,0.0005880847,0.003349473],"category_scores_gemma":[0.001073789,0.0001499845,0.0004295783,0.0007069369,0.0005274747,0.0004362577,0.0004854498,0.001205655,0.00059266],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.008880609,"about_ca_system_score_gemma":0.0100727,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.4197676,"about_ca_topic_score_gemma":0.6648629,"domain_scores_codex":[0.9997125,0.00004529209,0.00001284197,0.00003488276,0.00008633392,0.0001081325],"domain_scores_gemma":[0.9992782,0.00007422902,0.00005537638,0.00002190706,0.0001763889,0.0003937774],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.02401626,0.005972148,0.2450286,0.0009629967,0.0006316231,0.01436177,0.002129259,0.006734476,0.01167297,0.0034097,0.1298677,0.5552125],"study_design_scores_gemma":[0.01316873,0.01391838,0.5836356,0.001133227,0.001115491,0.01946489,0.003252088,0.004966212,0.003621361,0.001299099,0.3541251,0.0002998232],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9315278,0.01410064,0.0009168255,0.008114823,0.0003812483,0.0005659495,0.004175846,0.00006844682,0.04014841],"genre_scores_gemma":[0.9677044,0.01499701,0.002099776,0.00363576,0.0003093212,0.0001436592,0.005417442,0.0000799176,0.005612903],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5802324,"threshold_uncertainty_score":0.8346485,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02479497650447135,"score_gpt":0.4094396244081332,"score_spread":0.3846446479036618,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}